Latest Stock Buy or Sell? Make More Informed Decisions!
Today, Stan Wong commented about whether IJH-N, LII-N, GOOG-Q, XAGH-T, AGG-N, CAH-N, MCK-N, LLY-N, MRK-N, T-T, TOL-N, DOL-T, MS-N, GS-N, BAC-N, NVDA-Q, STZ-N, WMT-N, COST-Q, PG-N, LMT-N, CVS-N, CRWD-Q, FTNT-Q, NTR-T, NVO-N, MA-N, AMZN-Q, BCE-T, ARM-Q, URA-N, HURA-T, ZTS-N, NFLX-Q, CLS-T, XBAL-T, VBAL-T, VDY-T, XEI-T are stocks to buy or sell.
- Page 3/4
- Next Page
Pharmacy side not doing well, as people are switching to online. Pharmacy benefits are doing OK. Basing since May. Seems to be trying to get above water; just today got above the 200-day MA. See if it stays there.
Long term, managed care might be where they'll be OK. Valuation discount in the stock price, but it's a value trap. 9-10x forward earnings, but growth rate is under 2%. He doesn't like to buy on activist shareholders getting in, because you don't really know what's going to happen. He buys based on numbers, with earnings growth in high single digits.
Very stable, reliable earnings. Decent, but not fantastic, growth. About 7% earnings growth forecast for next little while, but you're paying 23-24x PE.
OK if you think a recession is around the corner. He doesn't, so he'd favour COST and WMT for continued mid-cycle economic growth.
Leader. Just when you think it's getting expensive on a PE basis, the earnings go up. Sees pretty strong earnings growth at over 40% over next few years. 39-40x PE, which is not expensive given the growth. Remember that the semi industry is highly cyclical. Great times now, but the tough times will eventually show up.
Be careful at $140, as that's where a recent top was. As well, over the years he's noticed that the time to be careful is when far too many people are interested in a stock. Might be priced for perfection.
Likes the money-centre banks like this one, as well as the investment-centred banks. US economy is improving. 12x PE, not expensive. 13-15% earnings growth for 2025 and 2026. Decent dividend of 2.6%, has grown by 9% a year over last 5 years. This is a more conservative play than banks like GS or MS.
Likes it. In mid-cap space. 200-day MA is trending higher, price is trending higher. Clear channel of higher highs and higher lows, so it looks good technically. Interest rates coming down could be beneficial. Growth rate ~9%, at 10.6x forward PE.
He doesn't own it because he owns only 35 names, can't own everything. But see his Top Picks ;)
Benefiting slightly from expectations of falling rates. Still below 200-day MA, which is a bit troublesome. A lot of the other dividend payers in Canada have done a bit better than telcos. Dividend yield of 7% is high, but pretty secure, with a 6% growth rate going forward. May need to sell assets as BCE did.
Healthcare space provides nice combination of growth with stability, in case we get into latter stage of economic cycle. Likes the space, but not this name. Price fell below 200-day MA in July, though that 200-day MA is moving higher. Technicals are not appealing.
He owns LLY and NVO, MCK and CAH.
He moved into CRWD on weakness. Really likes the space; attacks are only going to get more plentiful and more challenging. Stock's at a pivotal point, just peeked above the 200-day MA. Hard to say if it will get to the $400 level. In a limited space of competitors.